An HIV-prevention upgrade is badly needed. Since Truvada was approved as the first form of PrEP 12 years ago, the drug has failed to achieve anything in the U.S. approaching its awesome impact on ...

Truvada (emtricitabine/tenofovir disoproxil fumarate) is prescribed to treat and help prevent HIV-1. This drug can interact with other medications. For example, Truvada can interact with certain ...

How Was It Studied for the Prevention of HIV ... In both studies, Apretude was compared to Truvada, an HIV PrEP regimen recommended by the CDC and the United States Public Health Service.

The trial met its primary endpoint, showing the superiority of lenacapavir to Truvada for HIV prevention. Lenacapavir is already approved as an HIV treatment for patients resistant to other ...

New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV prevention in individuals who have sex ...

Per Gilead, the importance of studying HIV prevention across diverse global ... there are two FDA-approved daily oral medications for PrEP — Truvada and Descovy. Please note that Descovy for ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752) ...

Llenacapavir, a new HIV prevention injection, has been shown to have a 96% efficacy rate against the spread of the virus.

Lenacapavir and Truvada were both generally safe and well tolerated with ... "This is the second impressive result for this new HIV prevention option, opening up more possibilities for choice for even ...

Gilead said lenacapavir was 89 percent more effective than Truvada ... Centers for Disease Control and Prevention, and nearly 5,000 deaths. Nearly half of new HIV infections are in the South.

The program comprises five HIV prevention trials around the world ... U.S. full Prescribing Information for Truvada, including Boxed Warning, and lenacapavir are available at www.gilead.com.